{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:44:08Z","timestamp":1793159048954,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015383","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000}}],"reference-count":185,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015383.pub2","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T20:17:01Z","timestamp":1726085821000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases"],"prefix":"10.1002","volume":"2024","author":[{"given":"Sivan","family":"Schipper","sequence":"additional","affiliation":[{"name":"Department of Medicine; Spital Uster; Uster Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Nigam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Brigham and Women\u2019s Hospital; Boston USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Schmid","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research; University Hospital Basel and University of Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Piechotta","sequence":"additional","affiliation":[{"name":"Department for Infectious Disease Epidemiology; Robert Koch Institute; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ljuslin","sequence":"additional","affiliation":[{"name":"Palliative Medicine Division, Department of Rehabilitation and Geriatrics; Geneva University Hospitals; Geneva Switzerland"},{"name":"Department of Psychosocial Oncology and Palliative Care; Dana-Farber Cancer Institute; Boston USA"},{"name":"Harvard Medical School; Boston USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Beaussant","sequence":"additional","affiliation":[{"name":"Department of Psychosocial Oncology and Palliative Care; Dana-Farber Cancer Institute; Boston USA"},{"name":"Harvard Medical School; Boston USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Schwarzer","sequence":"additional","affiliation":[{"name":"Institute of Medical Biometry and Statistics; Faculty of Medicine and Medical Center, University of Freiburg; Freiburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Boehlke","sequence":"additional","affiliation":[{"name":"Department of Clinical Research; University Hospital Basel and University of Basel; Basel Switzerland"},{"name":"Palliative Care Center Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD015383.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0002|cit2","unstructured":"Gasser P Cochrane PAT review [personal communication] Email to: C Boehlke"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0003|cit3","unstructured":"Lysergic acid diethylamide (LSD)-assisted psychotherapy in people with illness-related anxiety clinicaltrials.gov\/study\/NCT00920387"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0004|cit4","unstructured":"Griffith R A single dose of psilocybin produces substantial and enduring decreases in anxiety and depression in patients with a life-threatening cancer diagnosis: a randomized double-blind trial Neuropsychopharmacology 2015 S90 1 10.1038\/npp.2015.324"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0005|cit5","unstructured":"Griffith R Cochrane meta-analyses for PAT in palliative care [personal communication] Email To: C Boehlke"},{"issue":"12","key":"10.1002\/14651858.CD015383.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0007|cit7","unstructured":"Psychopharmacology of psilocybin in cancer patients https:\/\/clinicaltrials.gov\/study\/NCT00465595"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0008|cit8","unstructured":"Grob C Psilocybin treatment for anxiety in patients with advanced-stage cancer Neuropsychopharmacology 2012 S15 10.1038\/npp.2012.218"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0010|cit10","unstructured":"Effects of psilocybin in advanced-stage cancer patients with anxiety clinicaltrials.gov\/study\/NCT00302744"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2022","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0012|cit12","unstructured":"Holze F Meta-analysis for Cochrane review Email To: C Boehlke"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0013|cit13","unstructured":"LSD treatment in persons suffering from anxiety symptoms in severe somatic diseases or in psychiatric anxiety disorders (LSD-assist) clinicaltrials.gov\/study\/NCT03153579"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Benville J Agin-Liebes G Roberts DE Lo S Ghazal L Effects of psilocybin on suicidal ideation in patients with life-threatening cancer Biological Psychiatry 2021 S235 S236 10.1016\/j.biopsych.2021.02.591","DOI":"10.1016\/j.biopsych.2021.02.591"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0016|cit16","unstructured":"Psilocybin cancer anxiety study clinicaltrials.gov\/study\/NCT00957359"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"American Chemical Society Pharmacology and Translational Science"},{"issue":"12","key":"10.1002\/14651858.CD015383.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1165-80","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0019|cit19","unstructured":"MDMA-assisted psychotherapy for anxiety associated with a life-threatening illness clinicaltrials.gov\/study\/NCT02427568"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"20442","DOI":"10.1038\/s41598-020-75706-1","article-title":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study","volume":"10","author":"Wolfson","year":"2020","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000467984","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof S Goodman","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0023|cit23","first-page":"446","article-title":"The experimental use of psychedelic (LSD) psychotherapy","volume":"4","author":"Pahnke","year":"1971","journal-title":"International Journal of Clinical Pharmacology, Therapy, and Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/02692163231172891","article-title":"Ketamine or placebo in patients with major depressive disorder undergoing palliative care: preliminary results from the KODIAC trial","volume":"37","author":"Rodriguez-Mayoral","year":"2023","journal-title":"Palliative Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3747\/co.26.5009","article-title":"Psychedelics for psychological and existential distress in palliative and cancer care","volume":"26","author":"Rosenbaum","year":"2019","journal-title":"Current Oncology (Toronto, Ont.)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"109174","DOI":"10.1016\/j.neuropharm.2022.109174","article-title":"Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care","volume":"216","author":"Ross","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0027|cit27","unstructured":"Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12619001225101"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0028|cit28","unstructured":"A feasibility study of psychedelic microdosing-assisted meaning centred psychotherapy in advanced stage cancer patients (PAM trial) www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=385810&isReview=true"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0029|cit29","unstructured":"Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-005037-32\/CZ"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0030|cit30","unstructured":"Conscious dying\/conscious living: ketamine-assisted psychotherapy (KAP) for patients at end of life - a pilot study for palliative and hospice care https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05214417"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0031|cit31","unstructured":"A phase 2b, randomized, double-blind, placebo-controlled, multi-center study of the effects of psilocybin-assisted psychotherapy on psychiatric and existential distress in advanced cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05398484"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0032|cit32","unstructured":"Pragmatic trial of psilocybin therapy in palliative care (PT2PC): a multicenter triple-blind phase 2 randomized controlled trial of psilocybin therapy for demoralized adults near the end of life https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05403086"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0033|cit33","unstructured":"Lysergic Acid Diethylamide (LSD) in palliative care: a randomised, double-blind, active-placebo controlled phase II study (LPC-study) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05883540"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00213-022-06123-7","article-title":"Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","volume":"239","author":"Aday","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatrica Scandivanica"},{"issue":"10","key":"10.1002\/14651858.CD015383.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S2215-0366(20)30146-2","article-title":"Psychedelic medicine: safety and ethical concerns","volume":"7","author":"Anderson","year":"2020","journal-title":"Lancet. Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD015383.pub2-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015061","article-title":"Interventions for palliative symptom control in COVID-19 patients","author":"Andreas","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD015383.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1002\/pon.4829","article-title":"Effects of existential interventions on spiritual, psychological, and physical well-being in adult patients with cancer: systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Bauerei\u00df","year":"2018","journal-title":"Psycho-oncology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0041|cit41","volume-title":"BDI Beck Depression Inventory Manual","author":"Beck","year":"1987"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1017\/S1478951514001217","article-title":"Assessment of spiritual suffering in the cancer context: a systematic literature review","volume":"13","author":"Best","year":"2015","journal-title":"Palliative & Supportive Care"},{"issue":"10","key":"10.1002\/14651858.CD015383.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/0269216315581538","article-title":"Treatment of holistic suffering in cancer: a systematic literature review","volume":"29","author":"Best","year":"2015","journal-title":"Palliative Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0005-7916(72)90045-6","article-title":"Credibility of analogue therapy rationales","volume":"3","author":"Borkovec","year":"1972","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jpainsymman.2010.05.010","article-title":"Existential suffering in the palliative care setting: an integrated literature review","volume":"41","author":"Boston","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1017\/S1478951519000191","article-title":"Exploring demoralization in end-of-life cancer patients: prevalence, latent dimensions, and associations with other psychosocial variables","volume":"17","author":"Bovero","year":"2019","journal-title":"Palliative & Support Care"},{"issue":"7","key":"10.1002\/14651858.CD015383.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1200\/JCO.2014.57.2198","article-title":"Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer","volume":"33","author":"Breitbart","year":"2015","journal-title":"Journal of Clinical Ocology"},{"issue":"7","key":"10.1002\/14651858.CD015383.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/pon.1627","article-title":"The association of depression and anxiety with health-related quality of life in cancer patients with depression and\/or pain","volume":"19","author":"Brown","year":"2020","journal-title":"Psycho-oncology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1020222","DOI":"10.3389\/fpsyg.2022.1020222","article-title":"Commentary: psychedelics and psychotherapy: cognitive-behavioral approaches as default","volume":"13","author":"Burton","year":"2022","journal-title":"Frontiers in Psychology"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007544.pub2","article-title":"Spiritual and religious interventions for well-being of adults in the terminal phase of disease","author":"Candy","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1265\u201383","DOI":"10.1093\/brain\/awq01","article-title":"The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas","volume":"133","author":"Carhart-Harris","year":"2010","journal-title":"Brain"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Frontiers in Human Neuroscience"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1002\/14651858.CD015383.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/02698811211008567","article-title":"Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?","volume":"36","author":"Carhart-Harris","year":"2022","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"887255","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-assisted psychotherapy-A systematic review of associated psychological interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Frontiers in Psychology"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"E471","DOI":"10.1097\/NCC.0000000000000925","article-title":"Existential distress in cancer patients: a concept analysis","volume":"45","author":"Chen","year":"2022","journal-title":"Cancer Nursing"},{"issue":"9181","key":"10.1002\/14651858.CD015383.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(99)80011-7","article-title":"Will to live in the terminally ill","volume":"354","author":"Chochinov","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1089\/jpm.2005.8.s-103","article-title":"Interventions to enhance the spiritual aspects of dying","volume":"8 Suppl 1","author":"Chochinov","year":"2005","journal-title":"Journal of Palliative Medicine"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jpainsymman.2007.12.018","article-title":"The patient dignity inventory: a novel way of measuring dignity-related distress in palliative care","volume":"36","author":"Chochinov","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0062|cit62","first-page":"96","article-title":"Demoralization, anhedonia and grief in patients with severe physical illness","volume":"4","author":"Clarke","year":"2005","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/026921639500900306","article-title":"The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability","volume":"9","author":"Cohen","year":"1995","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Cormier Z Psilocybin treatment for mental health gets legal framework; December 2020 Available at: www.scientificamerican.com\/article\/psilocybin-treatment-for-mental-health-gets-legal-framework\/","DOI":"10.1038\/scientificamerican022021-2ffaFDuGrrwBRn7C72RyS4"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0065|cit65","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 U.S. Department of Health and Human Services 2017"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1136990.","DOI":"10.3389\/fpsyt.2023.1136990","article-title":"Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective","volume":"14: Published o","author":"De La Haye","year":"2023","journal-title":"Frontiers in Psychiatry"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0067|cit67","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0068|cit68","volume-title":"BSI Brief Symptom Inventory: Administration, Scoring, and Procedures Manual.","author":"Derogatis","year":"1992"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"177\u201388","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0005-7916(00)00012-4","article-title":"Psychometric properties of the credibility\/expectancy questionnaire","volume":"31","author":"Devilly","year":"2000","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","article-title":"Studies with pain rating scales","volume":"37","author":"Downie","year":"1978","journal-title":"Annala of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0072|cit72","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"issue":"7109","key":"10.1002\/14651858.CD015383.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1037\/pst0000172","article-title":"The alliance in adult psychotherapy: A meta-analytic synthesis","volume":"55","author":"Fl\u00fcckiger","year":"2018","journal-title":"Psychotherapy (Chicago, Ill.)"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1037\/pha0000084","article-title":"Clinical applications of hallucinogens: a review","volume":"24","author":"Garcia-Romeu","year":"2016","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2021_268","volume-title":"Current Topics in Behavioral Neurosciences","author":"Gasser","year":"2022"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0077|cit77","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.esmoop.2023.101155","article-title":"Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline","volume":"8","author":"Grassi","year":"2023","journal-title":"ESMO Open"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD015383.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4614-4866-2_17","volume-title":"Psychological Aspects of Cancer","author":"Grob","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000467984","article-title":"LSD-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/10481885.2022.2106140","article-title":"A psychoanalytic perspective on psychedelic experience","volume":"32","author":"Guss","year":"2022","journal-title":"Psychoanalytic Dialogues"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/S0033291721004207","article-title":"Why was early therapeutic research on psychedelic drugs abandoned?","volume":"52","author":"Hall","year":"2022","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"7969","key":"10.1002\/14651858.CD015383.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/d41586-023-02093-8","article-title":"Australia to prescribe MDMA and psilocybin for PTSD and depression in world first","volume":"619","author":"Haridy","year":"2023","journal-title":"Nature"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0087|cit87","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0088|cit88","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0089|cit89","unstructured":"Higgins JPT Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1183\/09031936.00125707","article-title":"Anxiety and depression in end-stage COPD","volume":"31","author":"Hill","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bpsc.2024.01.007","article-title":"Serotonergic psychedelics: a comparative review of efficacy, safety, pharmacokinetics, and binding profile","volume":"9","author":"Holze","year":"2024","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"7","key":"10.1002\/14651858.CD015383.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"649\u201359","DOI":"10.1177\/02698811231180276","article-title":"Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review","volume":"37","author":"Hovmand","year":"2023","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.eclinm.2024.102711","article-title":"Ethnoracial inclusion in clinical trials of psychedelics: a systematic review","volume":"74","author":"Hughes","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"11","key":"10.1002\/14651858.CD015383.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0098|cit98","first-page":"80","article-title":"LSD and the dying patient","volume":"26","author":"Kast","year":"1966","journal-title":"Chicago Medical School Quarterly"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"271\u20137","DOI":"10.31887\/DCNS.2008.10.3\/shkennedy","article-title":"Core symptoms of major depressive disorder: relevance to diagnosis and treatment","volume":"10","author":"Kennedy","year":"2008","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/082585970402000402","article-title":"The Demoralization Scale: a report of its development and preliminary validation","volume":"20","author":"Kissane","year":"2004","journal-title":"Journal of Palliative Care"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis","volume":"322","author":"Ko","year":"2022","journal-title":"Journal of Affective Disorders"},{"issue":"11","key":"10.1002\/14651858.CD015383.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"13","key":"10.1002\/14651858.CD015383.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00213-017-4610-0","article-title":"Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation","volume":"234","author":"Kraehenmann","year":"2017","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD015383.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000055.pub2","article-title":"Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo","author":"Laursen","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0106|cit106","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Noel-Storr A Paynter R Rader T Thomas J Wieland LS Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated October 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cpr.2007.07.013","article-title":"Treatment of existential distress in life threatening illness: a review of manualized interventions","volume":"28","author":"LeMay","year":"2008","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0108|cit108","unstructured":"Li T Higgins JP Chapter 5: Collecting data. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"9-10","key":"10.1002\/14651858.CD015383.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00213-016-4453-0","article-title":"Alterations of consciousness and mystical-type experiences after acute LSD in humans","volume":"234","author":"Liechti","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"MacLean","year":"2011","journal-title":"Journal of Psychopharmacoly"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/s41591-021-01530-3","article-title":"Psychedelic therapy: a roadmap for wider acceptance and utilization","volume":"10","author":"Marks","year":"2021","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"e2414650","DOI":"10.1001\/jamanetworkopen.2024.14650","article-title":"Developing an ethics and policy framework for psychedelic clinical care: a consensus statement","volume":"7","author":"McGuire","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0113|cit113","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamapsychiatry.2023.0099","article-title":"Studying harms is key to improving psychedelic-assisted therapy-participants call for changes to research landscape","volume":"80","author":"McNamee","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0115|cit115","unstructured":"Excel Microsoft Corporation 2018"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0117|cit117","unstructured":"Mithoefer MC A manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder; Version 7 Available at maps.org\/research-archive\/mdma\/MDMA-Assisted-Psychotherapy-Treatment-Manual-Version7-19Aug15-FINAL.pdf"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003012.pub2","article-title":"Active placebos versus antidepressants for depression","author":"Moncrieff","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7-8","key":"10.1002\/14651858.CD015383.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.162","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Testing and Analysis"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"788155","DOI":"10.3389\/fphar.2021.788155","article-title":"Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.00","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Advances in Chronic Kidney Disease"},{"issue":"9","key":"10.1002\/14651858.CD015383.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0123|cit123","unstructured":"NHS Symptoms - Clinical depression; December 2019 Available at www.nhs.uk\/mental-health\/conditions\/clinical-depression\/symptoms\/"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","article-title":"Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens","volume":"18","author":"Nichols","year":"1986","journal-title":"Journal of Psychoactive Drugs"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacological Reviews"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ctrv.2017.03.012","article-title":"Psychotherapy for depression among advanced, incurable cancer patients: a systematic review and meta-analysis","volume":"56","author":"Okuyama","year":"2017","journal-title":"Cancer Treatment Reviews"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.1016\/j.jpainsymman.2022.01.024","article-title":"The therapeutic potential of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness: a systematic review","volume":"63","author":"Oliveira Maia","year":"2022","journal-title":"Journal of Pain and Symptom Mannagement"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0128|cit128","first-page":"16, 18","article-title":"Default mode network of the brain. Neurobiology and clinical significance","volume":"83","author":"Otti","year":"2012","journal-title":"Der Nervenarzt"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan - a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1207\/S15324796ABM2401_06","article-title":"Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp)","volume":"24","author":"Peterman","year":"2002","journal-title":"Annals of Behaviorial Medicine"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"k1415","DOI":"10.1136\/bmj.k1415","article-title":"Depression and anxiety in patients with cancer","volume":"361","author":"Pitman","year":"2018","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0134|cit134","unstructured":"Plotdigitizer free online app Porbital 2023 https:\/\/plotdigitizer.com\/"},{"issue":"7","key":"10.1002\/14651858.CD015383.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/SPC.0b013e328326b59b","article-title":"The detection of depression in palliative care","volume":"3","author":"Rayner","year":"2009","journal-title":"Current Opinion in Supportive and Palliative Care"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/0269216307087953","article-title":"Revisiting depression in palliative care settings: the need to focus on clinical utility over validity","volume":"22","author":"Reeve","year":"2008","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0139|cit139","volume-title":"Life Attitude Profile-Revised (LAP-R)","author":"Reker","year":"1992"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0140|cit140","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2024"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jpainsymman.2014.07.008","article-title":"A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research","volume":"49","author":"Robinson","year":"2015","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1037\/a0021767","article-title":"Assessing hopelessness in terminally ill cancer patients: development of the Hopelessness Assessment in Illness Questionnaire","volume":"23","author":"Rosenfeld","year":"2011","journal-title":"Psychological Assessment"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","article-title":"Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress","volume":"30","author":"Ross","year":"2018","journal-title":"International Review of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"American Chemical Society Pharmacology and Translational Science"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"109174","DOI":"10.1016\/j.neuropharm.2022.109174","article-title":"Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care","volume":"216","author":"Ross","year":"2022","journal-title":"Neuropharmacology."},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/SPC.0b013e32813aeb23","article-title":"Anxiety and its management in advanced cancer","volume":"1","author":"Roth","year":"2007","journal-title":"Current Opinion in Supportive and Palliative Care"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0147|cit147","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004596.pub3","article-title":"Drug therapy for symptoms associated with anxiety in adult palliative care patients","author":"Salt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/bmj.313.7072.1599","article-title":"Into the valley of the shadow of death: a personal therapeutic journey","volume":"313","author":"Saunders","year":"1996","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fphar.2018.00733","article-title":"Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development","volume":"9","author":"Schenberg","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review","volume":"239","author":"Schimmers","year":"2022","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD015383.pub2-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00213-017-4733-3","article-title":"Long-lasting subjective effects of LSD in normal subjects","volume":"235","author":"Schmid","year":"2018","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/0269881120959604","article-title":"Acute subjective effects in LSD- and MDMA-assisted psychotherapy","volume":"35","author":"Schmid","year":"2021","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0155|cit155","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Guyatt GH Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0156|cit156","first-page":"21","article-title":"A review of the use of LSD for the patient near death","volume":"3","author":"Sheehan","year":"1972","journal-title":"Psychiatric Forum"},{"issue":"15","key":"10.1002\/14651858.CD015383.pub2-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/BRS.0b013e3181c2a8d3","article-title":"Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain","volume":"35","author":"Sherman","year":"2010","journal-title":"Spine"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1191\/0269216303pm781oa","article-title":"Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer","volume":"17","author":"Smith","year":"2003","journal-title":"Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpainsymman.2005.06.00","article-title":"A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease","volume":"31","author":"Solano","year":"2006","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0162|cit162","volume-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1983"},{"issue":"10","key":"10.1002\/14651858.CD015383.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2d Half","key":"10.1002\/14651858.CD015383.pub2-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00221309.1970.9920634","article-title":"The construction and validation of a Death Anxiety Scale","volume":"82","author":"Templer","year":"1970","journal-title":"Journal of General Psychology"},{"issue":"1","key":"10.1002\/14651858.CD015383.pub2-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"e2945","DOI":"10.1002\/cpp.2945","article-title":"Therapeutic frameworks in integration sessions in substance-assisted psychotherapy: A systematised review","volume":"31","author":"Thal","year":"2024","journal-title":"Clinical Psychology & Psychotherapy"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1874473708666150107120930","article-title":"A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment","volume":"2","author":"Turton","year":"2014","journal-title":"Current Drug Abuse Reviews"},{"issue":"7","key":"10.1002\/14651858.CD015383.pub2-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00213-021-05817-8","article-title":"A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats","volume":"238","author":"Uthaug","year":"2021","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/pon.3417","article-title":"Symptom burden, loss of dignity, and demoralization in patients with cancer: a mediation model","volume":"23","author":"Vehling","year":"2014","journal-title":"Psycho-oncology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"2525\u201330","DOI":"10.1002\/pon.4872","article-title":"Existential distress in cancer: alleviating suffering from fundamental loss and change","volume":"27","author":"Vehling","year":"2018","journal-title":"Psycho-oncology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpsychores.2018.11.018","article-title":"Attachment security and existential distress among patients with advanced cancer","volume":"116","author":"Vehling","year":"2019","journal-title":"Jounral of Psychosomatic Research"},{"issue":"3","key":"10.1002\/14651858.CD015383.pub2-BIB0172|cit172","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011006.pub4","article-title":"Antidepressants for the treatment of depression in people with cancer (Review)","author":"Vita","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"611\u201324","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nature Review Neuroscience"},{"issue":"9","key":"10.1002\/14651858.CD015383.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1177\/10600280221144055","article-title":"Psychedelics for patients with cancer: a comprehensive literature review","volume":"57","author":"White","year":"2023","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0175|cit175","unstructured":"World Health Organization Palliative care; August 2020 Available at www.who.int\/news-room\/fact-sheets\/detail\/palliative-care"},{"issue":"12","key":"10.1002\/14651858.CD015383.pub2-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/s0277-9536(98)00009-4","article-title":"The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties","volume":"46","author":"The Whoqol Group","year":"1998","journal-title":"Social Science & Medicine"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1200\/JCO.2006.08.6801","article-title":"Suffering with advanced cancer","volume":"25","author":"Wilson","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"873279","DOI":"10.3389\/fpsyg.2022.873279","article-title":"Psychedelics and psychotherapy: Cognitive-behavioral approaches as default","volume":"13","author":"Yaden","year":"2022","journal-title":"Frontiers in Psychology"},{"issue":"4","key":"10.1002\/14651858.CD015383.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"e245960","DOI":"10.1001\/jamanetworkopen.2024.5960","article-title":"Acute adverse effects of therapeutic doses of psilocybina systematic review and meta-analysis","volume":"7","author":"Yerubandi","year":"2024","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/1740774512465064","article-title":"Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials","volume":"9","author":"Younger","year":"2012","journal-title":"Clinical Trials (London, England)"},{"key":"10.1002\/14651858.CD015383.pub2-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1017\/S2045796022000592","article-title":"Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study","volume":"31","author":"Zeilinger","year":"2022","journal-title":"Epidemiology and Psychiatric Science"},{"issue":"8","key":"10.1002\/14651858.CD015383.pub2-BIB0182|cit182","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/annonc\/mdx265","article-title":"First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study","volume":"28","author":"Zhu","year":"2017","journal-title":"Annals of Ocology"},{"issue":"6","key":"10.1002\/14651858.CD015383.pub2-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD015383.pub2-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1017\/S2045796018000227","article-title":"Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review","volume":"28","author":"Zwart","year":"2019","journal-title":"Epidemiology and Psychiatric Sciences"},{"issue":"11","key":"10.1002\/14651858.CD015383.pub2-BIB0185|cit185","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015383","article-title":"Psychedelic\/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care","author":"Schipper","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T08:43:45Z","timestamp":1763455425000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015383.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":185,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015383.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}